SCHEMBL197500

SCHEMBL197500

CCCOC(=O)C(N)CC(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.50
SLC1A3 P43003 2/20 0.39
SLC1A2 P43004 2/20 0.39
ANPEP P15144 5/20 0.38
RNPEP Q9H4A4 2/20 0.38
DNPEP Q9ULA0 1/20 0.38
TAS1R3 Q7RTX0 2/20 0.35
TAS1R1 Q7RTX1 2/20 0.35
HCAR2 Q8TDS4 1/20 0.35
LAP3 P28838 2/20 0.34
ERAP1 Q9NZ08 1/20 0.34
ALDH1A1 P00352 2/20 0.34
GRIK1 P39086 1/20 0.34
SLC1A1 P43005 1/20 0.34
GRIK2 Q13002 1/20 0.34
DPP4 P27487 1/20 0.34
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16857163 1.00 SLC7A5 (0.50) SLC7A5SLC1A3SLC1A2ANPEPRNPEP
SCHEMBL197501 1.00 SLC7A5 (0.50) SLC7A5SLC1A3SLC1A2ANPEPRNPEP
Hydrochloric Acid SCHEMBL2505696 0.98 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2ANPEPRNPEP
Hydrochloric Acid SCHEMBL16857161 0.98 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2ANPEPRNPEP
SCHEMBL13144609 0.89 SLC7A5 (0.56) SLC7A5SLC1A3SLC1A2ANPEPRNPEP
SCHEMBL31672557 0.89 SLC7A5 (0.44) SLC7A5SLC1A3SLC1A2ANPEPRNPEP
SCHEMBL2505997 0.88 ALDH1A1 (0.47) SLC7A5SLC1A3SLC1A2HCAR2ALDH1A1
SCHEMBL8435788 0.88 ALDH1A1 (0.47) SLC7A5SLC1A3SLC1A2HCAR2ALDH1A1
SCHEMBL8964483 0.88 ALDH1A1 (0.47) SLC7A5SLC1A3SLC1A2HCAR2ALDH1A1
SCHEMBL20509278 0.86 NAAA (0.46) SLC7A5SLC1A2HCAR2ALDH1A1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040435-A Mangiferin and derivatives thereof, preparation method and medical application thereof 安徽中医药大学 2025-05-27 CN disclosed
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
CN-113527152-B Biphenyl sulfonamide compound and method for controlling crop pests by using same 西北农林科技大学 2023-07-28 CN disclosed
WO-2023106377-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND 旭化成株式会社 2023-06-15 WO disclosed
CN-113527152-A Biphenylsulfonamide compound and method for preventing and treating crop pests by using same 西北农林科技大学 2021-10-22 CN disclosed
US-9745414-B2 Hyperbranched amino acid-based poly(ester urea)s for regenerative medicine and drug delivery BECKER MATTHEW (US) 2017-08-29 US disclosed
EP-2518080-B1 Antibiotic peptides AMP THERAPEUTICS GMBH (DE) 2016-05-18 EP disclosed
US-20150079163-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE NEXMED HOLDINGS, INC. 2015-03-19 US disclosed
US-20140357713-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE NEXMED HOLDINGS, INC. (US) 2014-12-04 US disclosed
US-8900625-B2 Antimicrobial compounds and methods of use NEXMED HOLDINGS, INC. (US) 2014-12-02 US disclosed
US-8158330-B2 Resist protective coating composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-04-17 US disclosed
US-8088537-B2 Resist top coat composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-01-03 US disclosed
CN-101456970-B Non-toxic fatty acid ester plasticiser mixture for polyvinyl chloride resin BEIJING CHARNA CHEMICALS LTD 2011-11-09 CN disclosed
CN-102020855-A Electrostatic spraying forming method of amino-acid ester substituted polyphosphazene microspheres UNIV BEIJING CHEMICAL 2011-04-20 CN disclosed
CN-101801995-A Antibacterial peptide AMP THERAPEUTICS GMBH & CO KG 2010-08-11 CN disclosed
CN-101597812-A The forming method of electrostatic spinning of amino-acid ester substituted polyphosphazene UNIV BEIJING CHEMICAL (CN) 2009-12-09 CN disclosed
US-20090286182-A1 RESIST PROTECTIVE COATING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-11-19 US disclosed
US-20090197200-A1 Resist top coat composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-08-06 US disclosed
CN-101456970-A Non-toxic fatty acid ester plasticiser mixture for polyvinyl chloride resin BEIJING CHARNA CHEMICALS LTD (CN) 2009-06-17 CN disclosed
US-4059589-A Process for formylation DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150079163-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE CLPP, POLR1C, NACA SLC7A5 3815/4885SLC1A3 4737/4885SLC1A2 4751/4885
US-20140357713-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE CLPP, POLR1C, NACA SLC7A5 3815/4885SLC1A3 4737/4885SLC1A2 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.